N-[(3R)-1-[2-[(10R,12S,17S,18R)-10-[[1-(4-fluorophenyl)triazol-4-yl]methoxy]-7,13-dioxo-24-(trifluoromethyl)-21-oxa-8,14,26-triazapentacyclo[20.3.1.12,6.114,18.08,12]octacosa-1(26),2(28),3,5,22,24-hexaen-17-yl]acetyl]pyrrolidin-3-yl]acetamide
C42H44F4N8O6 — CID 146117466
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(3R)-1-[2-[(10R,12S,17S,18R)-10-[[1-(4-fluorophenyl)triazol-4-yl]methoxy]-7,13-dioxo-24-(trifluoromethyl)-21-oxa-8,14,26-triazapentacyclo[20.3.1.12,6.114,18.08,12]octacosa-1(26),2(28),3,5,22,24-hexaen-17-yl]acetyl]pyrrolidin-3-yl]acetamide
N-[(3R)-1-[2-[(10R,12S,17S,18R)-10-[[1-(4-fluorophenyl)triazol-4-yl]methoxy]-7,13-dioxo-24-(trifluoromethyl)-21-oxa-8,14,26-triazapentacyclo[20.3.1.12,6.114,18.08,12]octacosa-1(26),2(28),3,5,22,24-hexaen-17-yl]acetyl]pyrrolidin-3-yl]acetamide (PubChem CID 146117466) has the molecular formula C42H44F4N8O6 and a molecular weight of 832.86 g/mol. Its IUPAC name is N-[(3R)-1-[2-[(10R,12S,17S,18R)-10-[[1-(4-fluorophenyl)triazol-4-yl]methoxy]-7,13-dioxo-24-(trifluoromethyl)-21-oxa-8,14,26-triazapentacyclo[20.3.1.12,6.114,18.08,12]octacosa-1(26),2(28),3,5,22,24-hexaen-17-yl]acetyl]pyrrolidin-3-yl]acetamide.
Molecular Properties
| Compound Name | N-[(3R)-1-[2-[(10R,12S,17S,18R)-10-[[1-(4-fluorophenyl)triazol-4-yl]methoxy]-7,13-dioxo-24-(trifluoromethyl)-21-oxa-8,14,26-triazapentacyclo[20.3.1.12,6.114,18.08,12]octacosa-1(26),2(28),3,5,22,24-hexaen-17-yl]acetyl]pyrrolidin-3-yl]acetamide |
|---|---|
| PubChem CID | 146117466 |
| Molecular Formula | C42H44F4N8O6 |
| Molecular Weight | 832.86 g/mol |
| Exact Mass | 832.33 |
| IUPAC Name | N-[(3R)-1-[2-[(10R,12S,17S,18R)-10-[[1-(4-fluorophenyl)triazol-4-yl]methoxy]-7,13-dioxo-24-(trifluoromethyl)-21-oxa-8,14,26-triazapentacyclo[20.3.1.12,6.114,18.08,12]octacosa-1(26),2(28),3,5,22,24-hexaen-17-yl]acetyl]pyrrolidin-3-yl]acetamide |
| SMILES | CC(=O)N[C@@H]1CCN(C(=O)C[C@@H]2CCN3C[C@@H]2CCOc2cc(C(F)(F)F)cc(n2)-c2cccc(c2)C(=O)N2C[C@H](OCc4cn(-c5ccc(F)cc5)nn4)C[C@H]2C3=O)C1 |
| InChI | InChI=1S/C42H44F4N8O6/c1-25(55)47-32-10-13-51(21-32)39(56)16-26-9-12-52-20-29(26)11-14-59-38-18-30(42(44,45)46)17-36(48-38)27-3-2-4-28(15-27)40(57)53-23-35(19-37(53)41(52)58)60-24-33-22-54(50-49-33)34-7-5-31(43)6-8-34/h2-8,15,17-18,22,26,29,32,35,37H,9-14,16,19-21,23-24H2,1H3,(H,47,55)/t26-,29-,32+,35+,37-/m0/s1 |
| InChIKey | TUUIRAVZZRGFHV-VQBIMERESA-N |
| XLogP | 4.66 |
| TPSA | 152.09 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 60 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 832.86 |
| LogP ≤ 5 | 4.66 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146117466 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.